Neoleukin Therapeutics Inc (NASDAQ:NLTX)

0.5915
Delayed Data
As of Feb 01
 -0.0036 / -0.60%
Today’s Change
0.38
Today|||52-Week Range
3.84
+16.21%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Neoleukin Therapeutics Inc have a median target of 1.00, with a high estimate of 2.00 and a low estimate of 0.90. The median estimate represents a +69.06% increase from the last price of 0.59.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Neoleukin Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.21
Sales
$0.00
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.83%
 
 
 
 
 
 
Growthannually 7.82%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.